Vaxart, Inc.
VXRT· OTC
VXRTVaxart, Inc.
Filed Nov 13, 2025 · 10-Q · 44 days after period end · 0001437749-25-034840
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $72.41M | $4.93M | $2.10M | $0.00 |
| Net Income | -$8.14M | -$14.08M | -$17.40M | -$29.31M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 13, 2025 · 44 d after period end
